ASCO Adapts CCO Guideline on Selection of Optimal Adjuvant Therapies for HER2-Negative and HER2-Posi

Virginia Cancer Specialists Practice Blog

September 12, 2016
Virginia Cancer Specialists » VCS Practice News » Blog Post » ASCO Adapts CCO Guideline on Selection of Optimal Adjuvant Therapies for HER2-Negative and HER2-Posi